chr16-67184714-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178516.4(EXOC3L1):c.2002G>A(p.Gly668Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000701 in 1,426,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EXOC3L1 | NM_178516.4 | c.2002G>A | p.Gly668Ser | missense_variant | 13/14 | ENST00000314586.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EXOC3L1 | ENST00000314586.11 | c.2002G>A | p.Gly668Ser | missense_variant | 13/14 | 2 | NM_178516.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000136 AC: 3AN: 220364Hom.: 0 AF XY: 0.0000165 AC XY: 2AN XY: 121174
GnomAD4 exome AF: 0.00000701 AC: 10AN: 1426968Hom.: 0 Cov.: 32 AF XY: 0.0000113 AC XY: 8AN XY: 707356
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.2002G>A (p.G668S) alteration is located in exon 13 (coding exon 12) of the EXOC3L1 gene. This alteration results from a G to A substitution at nucleotide position 2002, causing the glycine (G) at amino acid position 668 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at